diclofenac has been researched along with Porokeratosis in 7 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Porokeratosis: A heritable disorder of faulty keratinization characterized by the proliferation of abnormal clones of KERATINOCYTES and lesions showing varying atrophic patches surrounded by an elevated, keratotic border. These keratotic lesions can progress to overt cutaneous neoplasm. Several clinical variants are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, S | 1 |
| Takashima, Y | 1 |
| Hotta, M | 1 |
| Ito, E | 1 |
| Moriuchi, R | 1 |
| Otero-Rivas, MM | 1 |
| Rodríguez-Lojo, R | 1 |
| Castiñeiras-Mato, IM | 1 |
| Lueiro-Vilariño, M | 1 |
| Juárez-Casado, Y | 1 |
| Fernández-Díaz, ML | 1 |
| Marks, S | 1 |
| Varma, R | 1 |
| Cantrell, W | 1 |
| Chen, SC | 1 |
| Gold, M | 1 |
| Muellenhoff, M | 1 |
| Elewski, B | 1 |
| Skupsky, H | 1 |
| Skupsky, J | 1 |
| Goldenberg, G | 1 |
| Kluger, N | 1 |
| Dereure, O | 1 |
| Guilhou, JJ | 1 |
| Guillot, B | 1 |
| Wolf, JE | 1 |
| Taylor, JR | 1 |
| Tschen, E | 1 |
| Kang, S | 1 |
1 review available for diclofenac and Porokeratosis
| Article | Year |
|---|---|
Disseminated superficial actinic porokeratosis: a treatment review.
Topics: Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cholecalciferol; Dicl | 2012 |
1 trial available for diclofenac and Porokeratosis
| Article | Year |
|---|---|
Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses.
Topics: Administration, Topical; Adolescent; Adult; Analysis of Variance; Diclofenac; Double-Blind Method; D | 2001 |
5 other studies available for diclofenac and Porokeratosis
| Article | Year |
|---|---|
Inflammatory disseminated superficial porokeratosis successfully controlled with a combination of topical diclofenac gel and systemic etretinate.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Etretinate; Female; Gels; Humans; Poroker | 2018 |
Successful management of disseminated superficial actinic porokeratosis with diclofenac sodium 3% gel.
Topics: Administration, Cutaneous; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; F | 2017 |
Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis.
Topics: Adult; Diclofenac; Gels; Humans; Keratosis, Actinic; Pilot Projects; Porokeratosis; Surveys and Ques | 2009 |
Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
Topics: Administration, Cutaneous; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal | 2004 |
Genital porokeratosis: treatment with diclofenac topical gel.
Topics: Administration, Cutaneous; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; D | 2007 |